Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary resection for metastatic soft tissue sarcomas

A Kawai1, H Fukuma, Y Beppu

  • 1Department of Orthopaedic Surgery, Okayama University Medical School, Japan.

Clinical Orthopaedics and Related Research
|January 1, 1995
PubMed
Summary

Pulmonary resection for soft tissue sarcoma metastases offers a 5-year survival of 32%. Complete initial resection and a disease-free interval over 12 months significantly improve outcomes for these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Landscape of ultra-rare sarcomas: a nationwide study for epidemiology and prognosis.

ESMO open·2025
Same author

Translocation in bone and soft tissue sarcomas: a comprehensive epidemiological investigation.

ESMO open·2024
Same author

The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology.

ESMO open·2024
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Sarcoma Research

Background:

  • Metastatic soft tissue sarcomas often spread to the lungs, necessitating surgical intervention.
  • Pulmonary resection is a potential treatment option for selected patients with metastatic disease.

Purpose of the Study:

  • To analyze the therapeutic outcomes of pulmonary resections for metastatic soft tissue sarcomas.
  • To identify prognostic factors influencing survival after pulmonary resection for sarcoma metastases.

Main Methods:

  • Retrospective analysis of 23 patients undergoing 40 pulmonary resections for metastatic soft tissue sarcomas between 1970 and 1992.
  • Evaluation of patient demographics, tumor characteristics, treatment details, and survival data.
  • Statistical analysis to determine significant prognostic factors.

Related Experiment Videos

Main Results:

  • The 5-year overall survival rate was 32%, with a median survival of 28 months.
  • A disease-free interval of ≥12 months was associated with significantly longer survival (48.5% at 5 years) compared to <12 months (12%).
  • Complete initial resection without extensive chest-wall involvement improved 5-year survival to 44% versus 0% for incomplete resections.

Conclusions:

  • Pulmonary resection can be a valuable treatment for metastatic soft tissue sarcomas.
  • Achieving complete resection during the initial thoracotomy and ensuring a substantial disease-free interval are critical for long-term survival.